Mesoblast (ASX:MSB) said JPMorgan Chase & Co and its affiliates reduced their voting power in the company to 7.16% from 8.34% on Tuesday, according to a Friday filing with the Australian bourse.
The financial services firm and its affiliates reduced its shareholdings in the biotechnology firm to 82,2 million shares from 95.3 million shares as of the last notice dated Dec. 19, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments